3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
27
Burkitt Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasm Metastasis
4
Leukemia, Biphenotypic, Acute
4
Immunoglobulin Light-chain Amyloidosis
4
Smoldering Multiple Myeloma
3
Down Syndrome
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Lung Neoplasms
2
Hodgkin Disease
2
Breast Neoplasms
2
Brain Neoplasms
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Plasmacytoma
1
Myelodysplastic Syndromes
1
Meningioma
1
Mastocytosis, Systemic
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
pembrolizumab
139
Cisplatin
76
Cetuximab
53
Carboplatin
49
Paclitaxel
39
Nivolumab
39
Radiotherapy
37
Docetaxel
34
Radiotherapy, Intensity-Modulated
30
Magnetic Resonance Spectroscopy
25
Specimen Handling
20
Fluorouracil
20
Platinum
14
1,2-diaminocyclohexaneplatinum II citrate
13
Taxes
12
cemiplimab
11
Radiation
11
Ipilimumab
11
atezolizumab
10
Surgical Procedures, Operative
10
Drug Therapy
10
tislelizumab
9
Biopsy
9
durvalumab
8
Radiosurgery
8
Albumin-Bound Paclitaxel
8
130-nm albumin-bound paclitaxel
8
Standard of Care
7
Chemoradiotherapy
7
Immune Checkpoint Inhibitors
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
dexamethasone 21-phosphate
×
1 year
×
Clear all
No trials found.